This is a StreetInsider.com Premium Only Page

(ANAB) – Hot Corp. News

Oct 9, 2023 08:02 AM Anaptysbio (ANAB) Phase 3 Clinical Trial of Imsidolimab Met its Primary Endpoint

Mar 8, 2021 08:00 AM Anaptysbio (ANAB) Says Imsidolimab POPLAR Phase 2 Clinical Trial in Moderate-to-Severe Palmoplantar Pustulosis Did Not Meet Primary Endpoint

Nov 8, 2019 08:01 AM

Mar 26, 2018 04:07 PM

Nov 6, 2017 04:44 PM

Oct 13, 2017 05:36 AM

Oct 10, 2017 06:37 AM